{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:48:30Z","timestamp":1772754510888,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.autrev.2008.05.002","type":"journal-article","created":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T09:18:54Z","timestamp":1213435134000},"page":"104-106","source":"Crossref","is-referenced-by-count":46,"title":["Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases"],"prefix":"10.1016","volume":"8","author":[{"given":"I.","family":"Cavazzana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2008.05.002_bib1","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.05.002_bib2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.20702","article-title":"Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection","volume":"51","author":"Parke","year":"2004","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2008.05.002_bib3","first-page":"363","article-title":"Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis","volume":"18","author":"Mok","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2008.05.002_bib4","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/art.11301","article-title":"Infection and anti-tumor necrosis factor a therapy","volume":"48","author":"Ellerin","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.05.002_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-8278(99)80060-9","article-title":"Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity","volume":"30","author":"Zylberberg","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2008.05.002_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2249.1997.4861382.x","article-title":"Serum levels of IL-10, IL-15 and soluble tumor necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease","volume":"109","author":"Kakumu","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"(Suppl II","key":"10.1016\/j.autrev.2008.05.002_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2004.028209","article-title":"Safety of antitumor necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection","volume":"63","author":"Calabrese","year":"2004","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.autrev.2008.05.002_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tibtech.2004.08.011","article-title":"Biomedicines to reduce inflammation but not viral load in chronic HCV: what's the sense?","volume":"22","author":"Chuang","year":"2004","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.autrev.2008.05.002_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.05.002_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.05.002_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Eng J Med"},{"key":"10.1016\/j.autrev.2008.05.002_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.41.5.554","article-title":"Identification of antibodies to acidic antigens by counterimmunoelectrophoresis","volume":"41","author":"Bernstein","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2008.05.002_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.102.1.117","article-title":"Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus","volume":"102","author":"Clark","year":"1969","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2008.05.002_bib14","first-page":"731","article-title":"Purification and characterization of the Sj\u00f6gren's Syndrome A and B antigens","volume":"54","author":"Venables","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2008.05.002_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.md.0000157397.30055.c9","article-title":"Sj\u00f6gren Syndrome associated with hepatitis C virus: a multicenter analyses of 137 cases","volume":"84","author":"Ramos-Casals","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2008.05.002_bib16","first-page":"1","article-title":"Hepatitis C virus infection mimicking primary Sj\u00f6gren's Syndrome: a clinical and immunologic description of 35 cases","volume":"80","author":"Ramos-Casals","year":"2001","journal-title":"Medicine(Baltimore)"},{"key":"10.1016\/j.autrev.2008.05.002_bib17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/ard.62.11.1078","article-title":"Effect of tumor necrosis factor alpha antagonists on serum transaminases and viremia in patients with rheumatoid arthritis and chronic hepatitis C infection","volume":"62","author":"Peterson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2008.05.002_bib18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1440-1746.2006.04559.x","article-title":"Hepatitis B and C virus infections and anti-tumor necrosis factor-a therapy: guidelines for clinical approach","volume":"21","author":"Nathan","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2008.05.002_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1053\/gast.2002.31602","article-title":"Immunomodulatory drugs in Chron's disease patients with hepatitis B or C infection","volume":"122","author":"Biancone","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2008.05.002_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00042737-200102000-00016","article-title":"Infliximab treatment for Chron's disease in the presence of chronic hepatitis C infection","volume":"13","author":"Campbell","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:13:30Z","timestamp":1738260810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997208000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1568997208000785"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2008.05.002","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}